Ignite Creation Date:
2024-05-05 @ 5:03 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00377429
Status:
COMPLETED
Last Update Posted:
2012-07-19
First Post:
2006-09-15
Brief Title:
Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy
Sponsor:
Neovii Biotech
Organization:
Neovii Biotech
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Ovarian Cancer |
Keywords:
| Name | View |
|---|---|
| Epithelial Cancer | View |
| Epithelial Carcinoma | View |
| Epithelial Ovarian Cancer | View |
| Epithelial Ovarian Carcinoma | View |
| Fallopian Tube Cancer | View |
| Fallopian Tube Carcinoma | View |
| Ovarian Cancer | View |
| Ovarian Carcinoma | View |
| Ovarian Epithelial Cancer | View |
| Ovarian Epithelial Carcinoma | View |
| Peritoneal Cancer | View |
| Peritoneal Carcinoma | View |
| Advanced Epithelial Ovarian Cancer | View |